Overview

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

Status:
Withdrawn

Trial end date:
2005-03-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of celecoxib before prophylactic oophorectomy may be an effective way to prevent the development of ovarian epithelial cancer. PURPOSE: A controlled pilot trial to study the effectiveness of celecoxib in preventing cancer in patients at high-risk for ovarian epithelial cancer who are undergoing prophylactic oophorectomy.

Phase:

N/A

Details

Lead Sponsor:

University of Alabama at Birmingham

Collaborator:

National Cancer Institute (NCI)

Treatments:

Celecoxib